Norman LaFrance

Norman LaFrance

Corporate Officer/Principal at YMAS THER
78 year
Health Technology
Consumer Services
Health Services

Profile

Norman D.
LaFrance
is currently Chief Development Officer at Y-mAbs Therapeutics, Inc. since 2024.
Former positions include Chief Medical Officer & Senior Vice President at Plus Therapeutics, Inc. from 2021 to 2024; Chief Medical Officer & Senior Vice President at Jubilant Pharma Ltd. from 2012 to 2022; Global Chief Medical Officer at Zevacor Pharma, Inc. from 2010 to 2012; Chief Medical Officer & SVP-Clinical Development at Molecular Insight Pharmaceuticals, Inc. from 2007 to 2010; VP-Global Pharmaceutical Research & Development at Bausch & Lomb, Inc. from 2005 to 2007; and Senior Vice President-Medical & Regulatory Affairs at Celltech Americas, Inc. from 2002 to 2005.
Education includes undergraduate and graduate degrees from Rensselaer Polytechnic Institute and a doctorate from the University of Arizona.

Norman LaFrance active positions

CompaniesPositionStart
YMAS THER Corporate Officer/Principal 2024-06-04

Former positions of Norman LaFrance

CompaniesPositionEnd
CERENOME, INC. Chief Tech/Sci/R&D Officer 2024-06-10
Chief Tech/Sci/R&D Officer 2021-12-31
Chief Tech/Sci/R&D Officer 2021-10-31
Chief Tech/Sci/R&D Officer 2011-12-31
Chief Tech/Sci/R&D Officer 2010-11-04
See the detail of Norman LaFrance's experience

Training of Norman LaFrance

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Services

Consumer Services

Consumer Services

Health Technology

Celltech Americas, Inc.

Distribution Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Norman LaFrance
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!